ATOPIC DERMATITIS

This study tested an experimental drug called SAR444656 for adults with moderate to severe atopic dermatitis (eczema) that wasn't well-controlled with creams. Participants were randomly assigned to receive one of three doses of the drug or a placebo (inactive substance) for 16 we…

This early-stage study aimed to test the safety and side effects of a new drug called XmAb27564 in people with plaque psoriasis and atopic dermatitis (eczema). Participants received four injections of either the drug or a placebo over several weeks. The study was terminated early…

This early-stage study aimed to check the safety of an experimental drug called LY3872386 for treating atopic dermatitis (eczema). It involved a small group of healthy volunteers and people with eczema to see how their bodies handled the drug. The study was terminated early, so n…

This was an early-stage study to check the basic safety of a new injectable drug called NM26-2198 for people with moderate-to-severe eczema (atopic dermatitis). It involved 126 healthy volunteers and eczema patients to see how their bodies handled single and multiple doses. The m…

This was an early-stage study to check the safety of a new oral medication called IPG7236, intended for atopic dermatitis (eczema). It tested single and multiple doses in 63 healthy adults to see how the body processes the drug and if food affects it. The trial was terminated, me…

This early-stage study aimed to test the safety and effectiveness of an experimental drug called IMG-007 for adults with moderate-to-severe eczema (atopic dermatitis). Participants received the drug or a placebo through IV infusions over several weeks. The trial was terminated ea…

This study tested an experimental drug called LY3454738 to see if it could reduce the severity of moderate-to-severe eczema (atopic dermatitis) in adults. It was a Phase 2 trial involving 234 participants who were compared against a placebo group over 52 weeks. The main goal was …

This study tested whether a daily oral pill called RPT193 could reduce the severity of moderate-to-severe eczema (atopic dermatitis) in adults. It compared the drug to a placebo over 16 weeks to see if it improved skin symptoms and was safe. The trial has been terminated, meaning…

This study tested whether applying a prescription cream called ruxolitinib could help adults with atopic dermatitis (eczema) sleep better. It focused on people whose eczema itch was significantly disturbing their sleep. Researchers measured changes in total sleep time and sleep q…

This study aimed to better understand discomfort in babies under 6 months old with atopic dermatitis (eczema). Researchers filmed infants to analyze their behaviors, as traditional itch assessment tools don't work for this age group. The goal was to improve care by learning how t…

This Canadian study aimed to better understand eczema (atopic dermatitis) and compare two types of light therapy for treatment. Researchers enrolled 69 adults with moderate-to-severe eczema to track their disease, collect skin and blood samples for research, and test which form o…

This study aimed to understand how the drug tralokinumab works in the skin of people with moderate to severe eczema (atopic dermatitis). Researchers took skin and blood samples from 24 patients to measure the drug's levels and see how it changed the body's immune response. The go…